Description
Every year over 450000 people in Germany get cancer, 12000 of them are diagnosed with leukemia. At the Translational Centre for Regenerative Medicine (TRM) Leipzig researchers are developing an innovative treatment strategy based on micro RNAs. A successful blocking of these tiny molecules may cause the patient's malignant leukemia cells to mature into healthy blood cells.
To defeat leukemia in a long term, the TRM scientists are going one step further: They want to improve the stem cell transplantation, often the only curative regenerative treatment for leukemia. A specific antibody is intended to prevent mistakenly attacks of the transplanted cells against the patient's healthy tissues. This so-called graft versus host disease (GVHD) can be an accompanying serious complication of allogenic stem cell transplantation.
http://www.trm.uni-leipzig.de
Comments, questions and answers